1. Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma
   Ruida Hou et al, 2022, Cell Reports CrossRef
2. Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts
   Martyn A. Sharpe et al, 2023, International Journal of Molecular Sciences CrossRef